As cited by the research report titled ‘Global Contrast Enhanced Ultrasound Market Size study By Product (Equipment, Contrast Agents), By Type (Non-targeted, Targeted), By End-use (Hospitals, Clinics), and Regional Forecasts 2021-2027’, available with MarketStudyReport, global contrast enhanced ultrasound market was valued at USD 1.8 billion in 2020 and is estimated to record a CAGR of 4% over 2021-2027, subsequently accumulating a valuation of USD 2.37 billion by the end of forecast period.
 

Increasing prevalence of chronic diseases is a major factor driving global contrast enhanced ultrasound market growth. As per World Economic Forum, one in three adults worldwide is currently suffering from multiple chronic conditions at the same time.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4285134/
 

In addition, technological advancements and increasing product awareness are likely to generate lucrative opportunities for market development over the estimated timeline. On the downside, complex nature of the procedure could act as a bottleneck for the market progression over the projected timespan of 2021-2027.
 

For the record, contrast enhanced ultrasound (CEUS) is principally an application of ultrasound contrast medium in traditional medical sonography. During the process, the sound waves are reflected from interfaces between substances.
 

Based on product type, global contrast enhanced ultrasound industry is segmented into equipment, and contrast agents. By type, the marketplace is categorized into non-targeted, and targeted. The end user range includes clinics, hospitals, and ambulatory diagnostic centers.
 

The geographical analysis of the industry is studied for the major regions like North America, Asia Pacific, Europe, Latin America, and the rest of the world.
 

North America is expected to capture significant market share over the projected timeframe, on account of increasing adoption of enhanced ultrasound technology in abdominal & cardiac imaging as well as in research programs by sonologists & radiologists.
 

Meanwhile, Asia Pacific market is likely to witness considerable growth rate through 2027, owing to increasing healthcare expenditure.
 

Leading players profiled in global contrast enhanced ultrasound industry are Koninklijke Philips N.V, Acusphere Inc., Trivitron Healthcare Pvt. Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Esaote SpA, nanoPET Pharma GmbH, Siemens Healthineers AG, Bracco Diagnostics Inc., General Electric Company, and Lantheus Medical Imaging Inc.